Violin Jonathan's Form 4 filing
Viridian Therapeutics, Inc. (VRDN) · filed Feb 3, 2022
- Accession no.
- 0000899243-22-004665
- Filed
- Feb 3, 2022
- Trade date
- Feb 1-3, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $572.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Violin JonathanCIK 0001730615 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2022 | Common Stock | SSaleDisposed | −16,751 | $19.55 | −$327,482.05 | 614,154 | Direct | |
| Feb 2, 2022 | Common Stock | SSaleDisposed | −12,340 | $18.47 | −$227,919.8 | 601,814 | Direct | |
| Feb 3, 2022 | Common Stock | SSaleDisposed | −909 | $19.16 | −$17,416.44 | 600,905 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2022 | Common Stock | AGrant or awardAcquired | +280,000 | $0.00 | $0 | 280,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.